Charlestown, MA, United States of America

Carolyn Jordan

This inventor holds 1 USPTO granted patent. Top assignee: Transform Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carolyn Jordan. Retrieved from https://idiyas.com/inventor/carolyn-jordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Carolyn Jordan in Pharmaceutical Formulations

Introduction

Carolyn Jordan is an accomplished inventor based in Charlestown, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel formulations that combine fenofibrate and statins. Her work is aimed at improving treatment methods for various health conditions.

Latest Patents

Carolyn holds a patent for "Formulations comprising fenofibrate and a statin, and related methods of treatment." This invention provides innovative omega-3 oil formulations that effectively combine fenofibrate and a statin in small volumes. The related methods of treatment described in her patent offer new avenues for patient care.

Career Highlights

Throughout her career, Carolyn has been associated with Transform Pharmaceuticals, Inc., where she has been instrumental in advancing pharmaceutical research and development. Her expertise in formulation science has led to breakthroughs that enhance the efficacy of treatments.

Collaborations

Carolyn has worked alongside talented colleagues, including Orn Almarsson and Hector Guzman. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Carolyn Jordan's innovative work in pharmaceutical formulations exemplifies the impact of research and development in healthcare. Her contributions continue to pave the way for improved treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…